- ·Watch BostonGene: the Monday email on marks, rounds and moves
BostonGene funding history
No funding rounds for BostonGene are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
BostonGene valuation
BostonGene's last known valuation is $1.5 billion. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How BostonGene's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For BostonGene, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about BostonGene
- What is BostonGene worth?
- BostonGene's last known valuation is $1.5B.
- How much has BostonGene raised?
- BostonGene has raised $320.0M in total funding across its recorded rounds.